Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janiaud

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
BMJ Open|October 28, 2025
Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trialJohannes M Schwenke, Andreas M Schmitt, Stuart McLennan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 5, 2026
Non-genetic risk indicators for preterm birth: An umbrella review of systematic reviews and meta-analysesJ Klumper, L van Gils, R van Doornik, et al.
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
JAMA|February 26, 2021
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysisPerrine Janiaud, Cathrine Axfors, Andreas M Schmitt, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Journal of Clinical Epidemiology|September 3, 2025
Retrospective use of the PRECIS-2 trial design tool to assess design choices in randomised controlled trials; An empirical reviewAndrew Willis, Frances Shiely, Alison H Howie, et al.
Plos One|August 30, 2019
Limited evidence of physical therapy on balance after stroke: A systematic review and meta-analysisAurélien Hugues, Julie Di Marco, Shams Ribault, et al.
Current Medical Research and Opinion|January 24, 2025
Communicating scientific evidence: drugs for Alzheimer's disease as a case studyKasper P Kepp, Poul F Høilund-Carlsen, Ioana A Cristea, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Bulletin Du Cancer|April 22, 1999
[Inserm ad hoc committee: Recommendations for the management of women with a genetic risk for developing cancer of the breast and/or the ovary]F Eisinger, N Alby, A Bremond, et al.
BMJ Open|October 28, 2025
Mixed-methods process evaluation of ctDNA use to guide decision-making in patients with advanced solid cancers: study protocol for a substudy of the LIQPLAT trialJohannes M Schwenke, Andreas M Schmitt, Stuart McLennan, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 5, 2026
Non-genetic risk indicators for preterm birth: An umbrella review of systematic reviews and meta-analysesJ Klumper, L van Gils, R van Doornik, et al.
Annales D'Endocrinologie|April 6, 1999
[INSERM-FNCLCC collective expert's report. Recommendations for management of women having a genetic risk of developing breast and/or ovarian cancer. National Federation of Centers of the Fight Against Cancer]F Eisinger, N Alby, A Bremond, et al.
JAMA|February 26, 2021
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysisPerrine Janiaud, Cathrine Axfors, Andreas M Schmitt, et al.
Annales De Genetique|April 24, 1999
[INSERM-FNCLCC collective expertise. Recommendations for medical management of women with genetic risk of developing breast and/or ovarian cancer]F Eisinger, N Alby, A Bremond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 1998
Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc CommitteeF Eisinger, N Alby, A Bremond, et al.
Journal of Clinical Epidemiology|September 3, 2025
Retrospective use of the PRECIS-2 trial design tool to assess design choices in randomised controlled trials; An empirical reviewAndrew Willis, Frances Shiely, Alison H Howie, et al.
Plos One|August 30, 2019
Limited evidence of physical therapy on balance after stroke: A systematic review and meta-analysisAurélien Hugues, Julie Di Marco, Shams Ribault, et al.
Current Medical Research and Opinion|January 24, 2025
Communicating scientific evidence: drugs for Alzheimer's disease as a case studyKasper P Kepp, Poul F Høilund-Carlsen, Ioana A Cristea, et al.
Pageof 8